创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

抗癌肽的临床应用与研发进展

Clinical Application and Research Progress of Anticancer Peptides

  • 摘要: 癌症是严重威胁人类生命健康的重大疾病之一。传统的癌症治疗方法包括化疗、放疗等多种方法,但均具有相应的副作用或局限性,特别是对化疗药物产生的多药耐药性是癌症治疗的一大阻碍。肽疗法的兴起为癌症治疗提供了新的思路,肽因其靶向性、低毒性和高选择性而成为一类有前途的抗癌剂。综述抗癌肽(anticancer peptides,ACPs)的抗癌机制、临床应用、研发历程和计算机辅助ACPs设计,包括基于肽-蛋白质相互作用的设计和基于人工智能的设计,以期为新型ACPs类药物的设计研发提供参考。

     

    Abstract: Cancer is one of the major diseases that seriously threaten human life and health. Traditional cancer treatment methods include chemotherapy, radiotherapy, and various other methods, but they all have their own side effects or limitations. In particular, the development of multidrug resistance to chemotherapeutic agents is a major obstacle for cancer treatment. The rise of peptide therapy provides a new approach to cancer treatment, as peptides have become promising anticancer agents due to their targeting specificity, low toxicity, and high selectivity. This article provides a comprehensive review of the anticancer mechanisms, clinical applications, and research and development progress of anticancer peptides (ACPs), as well as the computer-aided design of ACPs, including peptide-protein interaction-based design and artificial intelligence-based design, aiming to provide some reference for the design and development of novel ACP drugs.

     

/

返回文章
返回